Gapping down
In reaction to disappointing earnings/guidance: FSC -13.7%, EXXI -7.9%, SOHU -7%, DO -3.3%, CYOU -2.4%, TE -2.2%, NAT -1.8%, CVM -0.7%
Select financial related names showing weakness: SAN -2.5%, BBVA -2.4%, ING -2.2%, IRE -2%, HSBC -1.9% (ICIJ said that HSBC sheltered murky cash linked to dictators and arms dealers), BCS -1.6%
Other news: RGLS -16.9% (announces top-line results from the 4 mg/kg cohort and additional results from the 2 mg/kg cohort in a completed clinical study evaluating RG-101), NBG -10.7% (Athens mktsweaker overnight following Greece PM comments re bailout extension), SHPG -2.5% (still checking), CLF -2.2% (Quebec Econ Minister provided Bloom Lake update and discussed potential suitors, according to reports out Friday afternoon), AAL -2% (reports January traffic results), TWTR -1.6% (weaker with Futures), OREX -1.5% (provides progress update on Mysimba EMA), GPRO -1.5% (cont weakness, down with Futures), NOK -1.4% (still checking), TSLA -1% (weaker with Futures), MCD -0.8% (January global comps -1.8% vs. 'negative' guidance)
Analyst comments: ANF -6.1% (downgraded to Underperform from Neutral at BofA/Merrill), SHAK -5% (initiated with an Underperform at Longbow), CENX -3.4% (downgraded to Underweight from Neutral at JP Morgan), PBR -2.4% (downgraded to Underperform from Neutral at Credit Suisse), SKX -2.3% (downgraded to Neutral from Buy at B. Riley & Co), AA -2.3% (downgraded to Neutral from Overweight at JP Morgan), HZO -2% (downgraded to Neutral from Buy at Longbow), BWLD -1.1% (downgraded to Hold from Buy at Miller Tabak), RF -1% (downgraded to Underperform from Mkt Perform at Keefe Bruyette), CMI -1% (downgraded to Neutral from Overweight at Atlantic Equities), PRU -1% (downgraded to Hold from Buy at Deutsche Bank)